UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012606
Receipt number R000014600
Scientific Title Effect of epicardial adipose tissue in atrial fibrillation
Date of disclosure of the study information 2013/12/17
Last modified on 2019/03/05 00:45:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of epicardial adipose tissue in atrial fibrillation

Acronym

AF and epicardial adipose tissue

Scientific Title

Effect of epicardial adipose tissue in atrial fibrillation

Scientific Title:Acronym

AF and epicardial adipose tissue

Region

Japan


Condition

Condition

atrial fibrillation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the epicardial adipose tissue by using a cardiac CT examination for patients with atrial fibrillation and to evaluate the relationship about the onset, the mechanism and pathology of atrial fibrillation.

Basic objectives2

Others

Basic objectives -Others

meaning of examination

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

recurrence of atrial fibrillation after catheter ablation therapy

Key secondary outcomes

1)distribution, accumulation and property of epicardial adipose tissue
2)blood examination
3)echocardiography


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Diagnosed as atrial fibrillation by electrocardiogram
2)After catheter ablation therapy for atrial ablation
3)cardiac CT examination before the ablation

Key exclusion criteria

1)moderate or severe valvular disease
2)reduced cardiac function (left ventricular ejection fraction<55%)
3)severe obese cases (BMI>30kg/m2)
4)heart failure cases (BNP>200pg/ml)
5)history of open-heart surgery
6)inflammatory or infection disease cases
7)Patients rejected the use of clinical data

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shuichi Kaneko

Organization

Kanazawa University Hospital

Division name

Department of Disease Control and Homeostasis

Zip code


Address

13-1 Takaramachi, Kanazawa city, Ishikawa, Japan

TEL

076-265-2233

Email

skaneko@m-kanazawa.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takashi Kusayama

Organization

Kanazawa University Hospital

Division name

Department of Cardiology

Zip code


Address

13-1 Takaramachi, Kanazawa city, Ishikawa, Japan

TEL

090-2838-0612

Homepage URL


Email

ojiichan519@gmail.com


Sponsor or person

Institute

Kanazawa University, Department of Disease Control and Homeostasis

Institute

Department

Personal name



Funding Source

Organization

Kanazawa University, Department of Disease Control and Homeostasis

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

金沢大学附属病院(石川県)


Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 17 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The mean epicardial addipose tissue density using CT was significantly higher in the patients with paroxysmal atrial fibrillation than in control patients.
Published from Journal of Cardiology. 2016; 68: 406-411.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 18 Day

Date of IRB


Anticipated trial start date

2013 Year 12 Month 17 Day

Last follow-up date

2015 Year 03 Month 31 Day

Date of closure to data entry

2015 Year 06 Month 30 Day

Date trial data considered complete

2015 Year 09 Month 30 Day

Date analysis concluded

2015 Year 12 Month 31 Day


Other

Other related information

We investigate the recurrence of atrial fibrillation after the catheter ablation, and evaluate the distribution,t and CT values of epicardial adipose tissue by cardiac CT.


Management information

Registered date

2013 Year 12 Month 17 Day

Last modified on

2019 Year 03 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014600


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name